High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming

Guangan Hu,Yang Su,Byong Ha Kang,Zhongqi Fan,Ting Dong,Douglas R Brown,Jaime Cheah,Karl Dane Wittrup,Jianzhu Chen

DOI: https://doi.org/10.1038/s41467-021-21066-x

2021-02-03

Abstract:Macrophages are plastic and, in response to different local stimuli, can polarize toward multi-dimensional spectrum of phenotypes, including the pro-inflammatory M1-like and the anti-inflammatory M2-like states. Using a high-throughput phenotypic screen in a library of ~4000 FDA-approved drugs, bioactive compounds and natural products, we find ~300 compounds that potently activate primary human macrophages toward either M1-like or M2-like state, of which ~30 are capable of reprogramming M1-like macrophages toward M2-like state and another ~20 for the reverse repolarization. Transcriptional analyses of macrophages treated with 34 non-redundant compounds identify both shared and unique targets and pathways through which the tested compounds modulate macrophage activation. One M1-activating compound, thiostrepton, is able to reprogram tumor-associated macrophages toward M1-like state in mice, and exhibit potent anti-tumor activity. Our compound-screening results thus help to provide a valuable resource not only for studying the macrophage biology but also for developing therapeutics through modulating macrophage activation.